Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing

por Sperotto, Alessandra, Bochicchio, Maria Teresa, Simonetti, Giorgia, Buccisano, Francesco, Peccatori, Jacopo, Piemontese, Simona, Calistri, Elisabetta, Ciotti, Giulia, Pierdomenico, Elisabetta, De Marchi, Roberta, Ciceri, Fabio, Gottardi, Michele
Publicado 2023

Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study)

por Bonifacio, Massimiliano, Binotto, Gianni, Tiribelli, Mario, Miggiano, Maria Cristina, Trawinska, Malgorzata Monika, Scaffidi, Luigi, Di Bona, Eros, Damiani, Daniela, Velotta, Vanessa, Ceccarelli, Giulia, Pierdomenico, Elisabetta, Loschirico, Mariella, Dubbini, Maria Vittoria, Cordioli, Maddalena, Ruggeri, Marco, Fanin, Renato, Semenzato, Gianpietro, Tacconelli, Evelina, Pizzolo, Giovanni, Krampera, Mauro
Publicado 2020

The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population

por Bonifacio, Massimiliano, Tiribelli, Mario, Miggiano, Maria Cristina, Abruzzese, Elisabetta, Binotto, Gianni, Scaffidi, Luigi, Cordioli, Maddalena, Damiani, Daniela, Di Bona, Eros, Trawinska, Malgorzata Monika, Tanasi, Ilaria, Dubbini, Maria Vittoria, Velotta, Vanessa, Ceccarelli, Giulia, Pierdomenico, Elisabetta, Lo Schirico, Mariella, Semenzato, Gianpietro, Ruggeri, Marco, Fanin, Renato, Tacconelli, Evelina, Pizzolo, Giovanni, Krampera, Mauro
Publicado 2021